INTERNATIONAL PATENT: 4TEEN4 PHARMACEUTICALS GMBH FILES APPLICATION FOR "USE OF ADRENOMEDULLIN OR FRAGMENTS THEREOF IN THE TREATMENT OF A PATIENT IN NEED THEREOF"

GENEVA, Dec. 9 -- 4TEEN4 PHARMACEUTICALS GMBH (NeuendorfstraBe 15A16761 Hennigsdorf) filed a patent application (PCT/EP2025/065185) for "USE OF ADRENOMEDULLIN OR FRAGMENTS THEREOF IN THE TREATMENT OF A PATIENT IN NEED THEREOF" on Jun 02, 2025. With publication no. WO/2025/248139, the details related to the patent application was published on Dec 04, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BERGMANN, Andreas (Am Rosenanger 7813465 Berlin)

Abstract: Subject matter of the present invention is adrenomedullin-Gly (SEQ ID NO: 6) or fragments or modifications thereof for use in the treatmen...